PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ischemic Attack

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic...

November 6, 2020

AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Minor Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Minor Acute Ischemic Stroke or High-R...

January 27, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us